In Vivo Alemtuzumab Enables Haploidentical Human Leukocyte Antigen-Mismatched Hematopoietic Stem-Cell Transplantation Without Ex Vivo Graft Manipulation-Reference-Cited by-同舟云学术

In Vivo Alemtuzumab Enables Haploidentical Human Leukocyte Antigen-Mismatched Hematopoietic Stem-Cell Transplantation Without Ex Vivo Graft Manipulation

Published:2005-05-27 Issue:10 Volume:79 Page:1351-1357
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Kanda Yoshinobu,Oshima Kumi,Asano-Mori Yuki,Kandabashi Koji,Nakagawa Masahiro,Sakata-Yanagimoto Mamiko,Izutsu Koji,Hangaishi Akira,Tsujino Shiho,Ogawa Seishi,Motokura Toru,Chiba Shigeru,Hirai Hisamaru

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference30 articles.

1. Hematopoietic cell transplantation.;Anasetti,1999

2. Clinical bone marrow and blood stem cell transplantation.;Beatty,2000

3. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991–2000).;Kanda;Blood,2003

4. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.;Anasetti;N Engl J Med,1989

5. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.;Aversa;N Engl J Med,1998

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-mismatched haploidentical transplantation using low-dose alemtuzumab;Journal of Hematopoietic Cell Transplantation;2021

2. Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation;Transplant Infectious Disease;2020-09-16

3. Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia;Haematologica;2020-04-30

4. Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide;Bone Marrow Transplantation;2020-03-23

5. Impact of the patient's body weight on the efficacy and adverse events of valganciclovir for cytomegalovirus reactivation after hematopoietic stem cell transplantation;Transplant Infectious Disease;2020-03-11